These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Reflections on prednisone therapy of patients with liver diseases]. Teichmann W Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):25-7. PubMed ID: 5501421 [No Abstract] [Full Text] [Related]
3. [Our experience with long-term therapy of chronic liver diseases using Superanabolon Spofa]. Svacinka P; Horký J; Blahníková L Vnitr Lek; 1970 Dec; 16(12):1181-7. PubMed ID: 5491517 [No Abstract] [Full Text] [Related]
4. [Treatment of chronic diseases of the liver]. Loginov AS Ter Arkh; 1977; 49(1):3-9. PubMed ID: 867234 [No Abstract] [Full Text] [Related]
5. [Nitrogen resorption and nitrogen retention in patients with chronic liver diseases]. Vetter K; Kaschube I; Lüder W; Aust L Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):61-4. PubMed ID: 5501430 [No Abstract] [Full Text] [Related]
6. [Therapy of liver diseases, possibilities and problems]. Renger F Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):9-13. PubMed ID: 4100481 [No Abstract] [Full Text] [Related]
7. [On the therapy of chronic inflammatory liver diseases without or with vitamin B 12-folic acid]. Burgmann W Munch Med Wochenschr; 1966 Sep; 108(37):1805-8. PubMed ID: 6014771 [No Abstract] [Full Text] [Related]
8. [Effect of anabolic steroids on protein metabolism under various protein administrations in chronic liver disease patients]. Blahníková L; Horký J Z Ernahrungswiss Suppl; 1972; 13():105-12. PubMed ID: 4510113 [No Abstract] [Full Text] [Related]
9. [Corticoid therapy in liver diseases]. Runcan V; Buligescu L Med Interna (Bucur); 1970 Mar; 22(3):259-64. PubMed ID: 5444364 [No Abstract] [Full Text] [Related]
10. [Hepagrisevit forte in chronic liver diseases]. Kollatz E; Kramer A; Schopper W; Siede W Med Klin; 1965 Dec; 60(50):2032-5. PubMed ID: 5331151 [No Abstract] [Full Text] [Related]
11. [Side-effects of glucocorticoids in liver therapy]. Möller E; Brinkmann W; Weber O; Wildhirt E Dtsch Med Wochenschr; 1969 Jun; 94(26):1371-3 passim. PubMed ID: 5787349 [No Abstract] [Full Text] [Related]
12. [Therapeutic efficiency of purified liver extract with an increased amount of vitamin B 12 in coenzymatic form in patients with liver diseases and rheumatoid arthritis]. Guglielmi G; Garbagnati N; Iaschi P; Ciavarelli F; Ferrantelli D Clin Ter; 1969 Nov; 51(3):227-44. PubMed ID: 5407318 [No Abstract] [Full Text] [Related]
13. [Experiences with Vitamin B-12 therapy of chronic liver diseases in a resort practice]. André W Munch Med Wochenschr; 1966 Mar; 108(11):610-1. PubMed ID: 6013869 [No Abstract] [Full Text] [Related]
14. [Immunosuppressive drugs in the treatment of liver diseases (author's transl)]. Magnenat P Ther Umsch; 1979 May; 36(5):432-8. PubMed ID: 451956 [No Abstract] [Full Text] [Related]
15. [Glucocorticoids in chronic liver diseases]. Maier KP; Talke H; Gerok W Dtsch Med Wochenschr; 1975 Mar; 100(11):560-3. PubMed ID: 1116441 [No Abstract] [Full Text] [Related]
16. [Glucocorticoids and immunosuppressive agents in liver diseases]. Arpa Gutierrez FJ; Silva Pozo J Rev Esp Enferm Apar Dig; 1970 Dec; 32(7):763-82. PubMed ID: 4926636 [No Abstract] [Full Text] [Related]
17. [Therapy of chronic hepatitis and liver cirrhosis with the oral antidiabetic tolbutamide (Orabet)]. Schimmelpfennig W; Wagner K; Schneider G; Theuer D; Schimmelpfennig R; Zimmermann HB; Hecht A Dtsch Gesundheitsw; 1969 Oct; 24(44):2074-9. PubMed ID: 5385540 [No Abstract] [Full Text] [Related]
18. [Therapeutic effectiveness of B-vitamins and other drugs in chronic liver-parenchyma diseases?]. Heinrich HC Munch Med Wochenschr; 1968 Oct; 110(40):2311-2. PubMed ID: 5761604 [No Abstract] [Full Text] [Related]
19. [Therapeutic effectiveness of B-vitamins and other drugs in chronic liver-parenchyma diseases?]. Wildhirt E Munch Med Wochenschr; 1968 Oct; 110(40):2313-4. PubMed ID: 5761605 [No Abstract] [Full Text] [Related]
20. [Indications, method and effectiveness of immunosuppressive treatment in chronic active hepatopathies. I. Changes in the general dynamics of the disease. II. Slowing-down of the chronicization process]. Nicolaescu T; Stoiculescu P; Bittman E; Bordeianu A; Gheorghe N; Pintilescu V; Metz L Med Interna (Bucur); 1974 Apr; 26(4):453-64. PubMed ID: 4839352 [No Abstract] [Full Text] [Related] [Next] [New Search]